Press-release for stocks related to earnings

Prices are updated after-hours

tags : Earnings

save search

Regeneron to Host Investor Call and Webcast on December 14, 2023 to Provide Updates Across Its Hematology Portfolio
Published: 2023-11-30 (Crawled : 00:00) - biospace.com/
REGN | $814.86 -1.09% 0.31% 560K

Health Technology

| 3.6% | O: 1.65% H: 0.0% C: 0.0%

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
Published: 2023-11-30 (Crawled : 00:00) - biospace.com/
CDMO | $4.995 -1.87% -0.5% 2.1M

Health Technology

| Email alert Add to watchlist
report year financial results market

Arrowhead Pharmaceuticals Reports Fiscal 2023 Year End Results
Published: 2023-11-29 (Crawled : 00:00) - biospace.com/
JNJ | $158.38 2.41% 0.0% 10M

Health Technology

| 3.36% | O: -0.04% H: 0.0% C: 0.0%
ARWR | $23.17 9.29% -1.55% 4.2M

Health Technology

| -2.44% | O: 0.62% H: 0.0% C: 0.0%
year pharmaceuticals results

Satellos Bioscience Announces 2023 Q3 Financial Results and Operational Highlights
Published: 2023-11-22 (Crawled : 17:00) - biospace.com/
MSCLF | $0.35 -2.97% 2.89% 4K

n/a

| Email alert Add to watchlist
bioscience financial results

Pressure BioSciences, Inc. Reports Q3 2023 Financial Results, Provides Business Update, and Offers Guidance for Remainder of 2023
Published: 2023-11-21 (Crawled : 17:00) - biospace.com/
PBIO | $0.499 10.89% -35.87% 51K

Health Technology

| -4.0% | O: -2.08% H: 7.23% C: -6.05%
business financial

Agilent Reports Fourth-Quarter Fiscal Year 2023 Financial Results
Published: 2023-11-20 (Crawled : 00:00) - biospace.com/
A A | $128.79 0.78% 0.16% 1.7M

Health Technology

| 12.95% | O: 0.15% H: 0.0% C: 0.0%
year financial results

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ET
Published: 2023-11-20 (Crawled : 00:00) - biospace.com/
ENTA | $9.76 4.5% 0.0% 210K

Health Technology

| 7.48% | O: 4.66% H: 0.0% C: 0.0%
conference year pharmaceuticals financial results today

Pressure BioSciences, Inc. to Discuss Third Quarter 2023 Financial Results and Provide Business Update
Published: 2023-11-20 (Crawled : 19:00) - biospace.com/
PBIO | $0.499 10.89% -35.87% 51K

Health Technology

| -18.63% | O: -15.24% H: 0.0% C: 0.0%
business update financial results

Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
Published: 2023-11-17 (Crawled : 17:00) - biospace.com/
TWST | $24.78 3.03% -0.04% 1.4M

Health Technology

| 26.11% | O: 8.91% H: 0.0% C: 0.0%
year bioscience financial results

Johnson & Johnson to Host Enterprise Business Review
Published: 2023-11-16 (Crawled : 17:00) - biospace.com/
JNJ | $158.38 2.41% 0.0% 10M

Health Technology

| 6.13% | O: 1.4% H: 0.0% C: 0.0%
business review

Athersys Reports Third Quarter 2023 Financial Results and Business Highlights
Published: 2023-11-16 (Crawled : 14:30) - biospace.com/
ATHX | $0.1018 -40.86% 95M

Health Technology

| Email alert Add to watchlist
business financial results

Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
Published: 2023-11-15 (Crawled : 00:00) - biospace.com/
VRPX | $0.3952 -1.15% -0.03% 6.4K

| -47.61% | O: -4.21% H: 0.0% C: 0.0%
virpax pharmaceuticals results

MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
Published: 2023-11-15 (Crawled : 00:00) - biospace.com/
XNCR | $18.8 2.51% 0.0% 620K

Health Technology

| 7.57% | O: 5.45% H: 0.0% C: 0.0%
MOR | $7.01 2.49% -0.57% 2.4M

Health Technology

| -17.37% | O: -1.63% H: 0.0% C: 0.0%
financial results

Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
Published: 2023-11-15 (Crawled : 15:30) - biospace.com/
CYTH | $1.47 2.08% 4.76% 23K

Professional, Scientific, and T...

| -1.37% | O: -10.27% H: 13.74% C: 10.69%
RFL | $1.83 2.81% 0.0% 31K

Finance

| -2.73% | O: 2.73% H: 0.0% C: -4.79%
AMTI S | $0.2057 5.54% -2.82% 170K

Health Technology

| 16.57% | O: -10.29% H: 16.6% C: 9.53%
therapeutics financial results

Catalent, Inc. Reports Preliminary First Quarter Fiscal 2024 Results and Reaffirms Full-Year Fiscal 2024 Guidance
Published: 2023-11-15 (Crawled : 15:30) - biospace.com/
CTLT | $40.15 3.35% 0.0% 2.1M

Health Technology

| 19.55% | O: 9.09% H: 12.38% C: 9.55%
results

Evogene Reports Third Quarter 2023 Financial Results
Published: 2023-11-15 (Crawled : 15:30) - biospace.com/
EVGN | $0.691 6.28% 0.0% 150K

Health Technology

| 7.12% | O: 12.03% H: 0.0% C: -2.71%
financial results

Cybin Reports Second Quarter Financial Results and Recent Business Highlights
Published: 2023-11-15 (Crawled : 08:00) - biospace.com/
CYBN | $0.46 2.2% 0.0% 4.4M

n/a

| -6.21% | O: -3.94% H: 1.74% C: -1.3%
business financial results

Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update
Published: 2023-11-14 (Crawled : 15:30) - biospace.com/
SHPH | $0.5001 0.04% 2.58% 15K